Month: June 2022

NoHo Partners Plc STOCK EXCHANGE RELEASE 9 June 2022 at 10:15 a.m. NoHo Partners Plc to re-organise its Leadership Team NoHo Partners Plc has re-organised the structure of its Leadership Team to accelerate its new growth strategy. With the changes made, the company seeks clearer accountability and allocation of resources behind its strategic growth platforms. At the same time, the company will strengthen the role of country-specific Leadership Teams and invest in the future growth and internationalisation of the Fast Food business. The company’s strategy and its implementation, financing, acquisitions and procurement will be concentrated in the Group operations. Aku Vikström will continue as the Group CEO and Chairman of the Group’s Executive Team. The other members of the Group’s Executive Team are Deputy CEO Jarno Suominen, CFO...

Montrouge, France, June 9, 2022 DBV Technologies Announces Private Placement Financing of $194 Million DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Global Select Market: DBVT), a clinical-stage biopharmaceutical company, today announced an aggregate $194 million private investment in public equity (PIPE) financing (corresponding to €181 million on the basis of an exchange rate of $1.0739 = €1.00 published by the European Central Bank on June 8, 2022) from the sale of 32,855,669 ordinary shares, as well as pre-funded warrants to purchase up to 28,276,331 ordinary shares. The ordinary shares will be sold to the purchasers at a price per ordinary share of €3.00 (corresponding to $3.22), and the pre-funded warrants will be sold to the purchasers at a pre-funded price of €2.90 (corresponding to $3.11) per pre-funded warrant,...

Issuance target remains unchangedIn order to ensure continuity in the issuance, the issuance target for bonds is maintained at  kr. 65 billion and at kr. 35 billion for short-term borrowing. A high central government  account balance ensures flexibility in the issuance scopeIn case of limited investor demand in the rest of the year, the high central government account balance gives the central government the option to issue less than the issuance target. New inflation-linked bond will be opened in SeptemberFollowing the opening, the new inflation-linked government bond will regularly be offered at the auctions and in switch operations.AttachmentANALYSE_No 7_Central government borrowing strategy in the 2nd half of 2022 [9-6-2022]

In the Phase III IMpower010 trial, adjuvant Tecentriq reduced the risk of disease recurrence or death by 57% in people with PD-L1 high resected Stage II-III NSCLC, compared with best supportive care Tecentriq is now the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe Today’s approval marks Tecentriq’s sixth lung cancer indication in EuropeBasel, 09 June 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq® (atezolizumab) as an adjuvant treatment, following complete resection and platinum-based chemotherapy, for adults with non-small cell lung cancer (NSCLC) with a high risk of recurrence* whose tumours express PD-L1≥50% and who do not have EGFR mutant or ALK-positive NSCLC. “Today’s approval represents an important advance,...

Pratteln, Switzerland, and Rockville, MD, USA, June 9, 2022 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce presentations of new data with vamorolone in Duchenne muscular dystrophy (DMD). Cross-study comparisons of long-term efficacy, impact on growth velocity, and frequency and severity of spinal fractures for vamorolone versus current standard of care from the Phase 2b VISION-DMD study and the FOR-DMD study will be presented during the poster session at the 2022 Annual Conference of Parent Project Muscular Dystrophy (PPMD) to be held from June 23-26, 2022, in Scottsdale, AZ, USA. “Data being presented by our academic collaborators at PPMD this year will provide further insight into our understanding of the potential of a dissociative steroid, such as vamorolone, in maintaining muscle strength whilst addressing...

The net asset value (NAV) of EfTEN Real Estate Fund III AS was 19.0549 euros as of 31.05.2022, increasing by 0.8% during May. The net asset value of the EPRA share (EPRA NRV – net book value excluding the deferred income tax liability and the fair value of interest rate derivatives) was 20.24 euros as of 31.05.2022. EPRA NAV also increased by 0.8% in May. In May, the fund earned a total of 1,112 thousand euros in consolidated rental income, which is 10 thousand euros more than a month earlier. The increase is mainly due to the first full month’s rent of the Valkla care home property. The Fund’s consolidated EBITDA was 981 thousand euros in May (April: 963 thousand euros). During the five months of 2022, the fund has earned a total of 5,498 thousand euros in rental income and 4,851 thousand euros in EBITDA, including EBITDA...

Further to our Press Release of 4 May 2022, Awilco Drilling Plc announces that its fully owned subsidiary, Awilco Drilling Offshore (UK) Limited, has now concluded the previously announced sale of the drilling rig WilPhoenix. Concurrent with this transaction, the short-term shareholder loan with Awilhelmsen Offshore AS and QVT Family Office Fund LP has been redeemed. WilHunter, Awilco Drilling’s other semi-submersible, is in the process of being sold for recycling. Aberdeen, 9 June 2022For further information please contact: Eric Jacobs, Interim CEOPhone: +44 1224 737900 Cathrine Haavind, Investor RelationsPhone: +47 93 42 84 64Email: ch@awilcodrilling.com This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.